0000950170-23-064579.txt : 20231116
0000950170-23-064579.hdr.sgml : 20231116
20231116173520
ACCESSION NUMBER: 0000950170-23-064579
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230608
FILED AS OF DATE: 20231116
DATE AS OF CHANGE: 20231116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Encrantz Staffan
CENTRAL INDEX KEY: 0001870875
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40587
FILM NUMBER: 231415687
MAIL ADDRESS:
STREET 1: C/O SIGHT SCIENCES, INC.
STREET 2: 4040 CAMPBELL AVENUE, SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sight Sciences, Inc.
CENTRAL INDEX KEY: 0001531177
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 800625749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3000 SAND HILL ROAD
STREET 2: BUILDING 3, SUITE 105
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: (415) 889-0550
MAIL ADDRESS:
STREET 1: 3000 SAND HILL ROAD
STREET 2: BUILDING 3, SUITE 105
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4/A
1
ownership.xml
4/A
X0508
4/A
2023-06-08
2023-06-12
0001531177
Sight Sciences, Inc.
SGHT
0001870875
Encrantz Staffan
C/O SIGHT SCIENCES, INC.
4040 CAMPBELL AVE., SUITE 100
MENLO PARK
CA
94025
true
false
true
false
false
Common Stock
2023-06-08
4
A
false
11940
0
A
11940
D
Common Stock
2023-06-08
4
A
false
15094
0
A
27034
D
Common Stock
1184258
I
See footnote
Common Stock
4022118
I
See footnote
Reflects the vesting in full of 11,940 restricted stock units ("RSUs") granted to the Reporting Person on June 8, 2022 under the Issuer's Non-Employee Director Compensation Program (the "Program"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on August 5, 2022. Each RSU represented a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock").
Reflects a grant of RSUs made to the Reporting Person under the Program. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on the earlier of June 8, 2024 and the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Issuer's board of directors through such vesting date.
These shares of Common Stock are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (the "Trust"). The Reporting Person is a trustee of the Trust and may be deemed to beneficially own the shares held by the Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Trust (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any. These shares include 632,456 shares of Common Stock that were previously distributed by Allegro Investors LLC to the Trust (its sole member) for no consideration.
These shares of Common Stock are held of record by Allegro Investment Fund, L.P. ("Allegro Investment Fund"). The Reporting Person is the President of Allegro Investment Inc., the investment manager of Allegro Investment Fund, and may be deemed to beneficially own the shares held by Allegro Investment Fund. The Reporting Person disclaims beneficial ownership of the shares held by Allegro Investment Fund (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any.
This amendment is being filed to report the shares of Common Stock, that were beneficially owned by the Reporting Person as of June 12, 2023, which were inadvertently omitted in the original Form 4.
/s/ Jeremy Hayden, Attorney-in-Fact for Staffan Encrantz
2023-11-16